Results
1
High return on equity, past performance and sound balance sheet.
1 companies
Gubra
Market Cap: DKK 5.5b
A disease-agnostic techbio company, focuses on the peptide-based drug discovery and preclinical contract research services in Europe, North America, and internationally.
GUBRA
DKK 322.00
7D
0.3%
1Y
-19.3%